MILAN, ITALY -- (Marketwire) -- 08/05/11 -- MolMed S.p.A. (MILAN: MLM) today announced that it has…
Continue ReadingTag: molmed
MolMed Board of Directors Approves the Financial Report for the First Half-Year 2011
- New Promising Results of Six Clinical Trials of Its Investigational Anticancer Drugs NGR-hTNF and TK,…
Continue Reading